Sell side looks sickening at the moment. Timelines have been blown out ridiculously and now moving forward we can only hope an ilumen deal is struck that actually produces a meaningful revenue figure. It’s going to need something special to put a spark in the share price. It always makes me wonder how a SPP can be heavily oversubscribed yet there is a heap on offer at a less price and nobody wants to touch it
Ann: Medibio Quarterly Update and Cashflow Report, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
